|
Q4 2017
Filed on Feb 14, 2018
|
3,710
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
6,000
|
$21.48 - $24.17
$129K - $145K
|
|
Oppenheimer Rev Weightd ETF
|
Q4 2017
Filed on Feb 14, 2018
|
1,219
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
200
|
$9.47 - $19.59
$1.89K - $3.92K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
150
|
$11.23 - $19.1
$1.68K - $2.87K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
100
|
N/A
|
|
Stemline Therapeutics Inc
|
Q4 2017
Filed on Feb 14, 2018
|
300
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
1,480
|
$35.54 - $37.2
$52.6K - $55.1K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
102
|
$62.76 - $66.17
$6.4K - $6.75K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
100
|
$40.63 - $50.91
$4.06K - $5.09K
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
53
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
141
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
300
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
200
|
$15.81 - $24.01
$3.16K - $4.8K
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
300
|
$8.4 - $15.0
$2.52K - $4.5K
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
4
|
$64.06 - $71.42
$256 - $286
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
38
|
$23.19 - $23.95
$881 - $910
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
3,170
|
$31.66 - $37.16
$100K - $118K
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
300
|
$20.29 - $29.88
$6.09K - $8.96K
|
|
Merrimack Pharmaceuticals In
|
Q3 2017
Filed on Nov 15, 2017
|
300
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
1,011
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
150
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
75
|
$5.13 - $6.3
$385 - $473
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
2,110
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
30
|
$49.89 - $50.38
$1.5K - $1.51K
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
5,170
|
$32.43 - $35.14
$168K - $182K
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
3
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
200
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
46
|
$36.38 - $47.5
$1.67K - $2.19K
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
5,400
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
1,333
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
1,800
|
$38.75 - $46.9
$69.8K - $84.4K
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
550
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
200
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
96
|
$13.96 - $14.48
$1.34K - $1.39K
|
|
Du Pont E I De Nemours & CO
|
Q3 2017
Filed on Nov 15, 2017
|
1,156
|
N/A
|
|
Twenty First Centy Fox Inc
|
Q3 2017
Filed on Nov 15, 2017
|
493
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
200
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
601
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
272
|
$53.03 - $64.84
$14.4K - $17.6K
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
1
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
4,885
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
3,170
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
34
|
$77.05 - $85.3
$2.62K - $2.9K
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
402
|
$66.62 - $75.49
$26.8K - $30.3K
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
1,500
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
206
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
3,040
|
$37.98 - $44.17
$115K - $134K
|
|
Aevi Genomic Medicine Inc
|
Q3 2017
Filed on Nov 15, 2017
|
300
|
N/A
|
|
|
Q3 2017
Filed on Nov 15, 2017
|
640
|
N/A
|
|